SPY766.01−0.69%QQQ737.38−0.96%BTC/USD83,266.00−1.40%DIA514.19−0.64%GLD378.98−3.67%TLT78.53−1.00%
Benzinga

NRX Pharmaceuticals Inc (NRXP) Stock Price, Quote, News & History

NRXPNASDAQ
Trade with Public
Trade with Public
$2.97
-0.025-0.83%
Last update: Sep 28, 3:27 PM
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentOwnershipCompareOptionsStock Report

NRX Pharmaceuticals (NRXP) Stock Price, Quote, News & History | Benzinga

Key Statistics

Open
$2.95
Close
-
Volume / Avg.
565.96K / 898.40K
Day Range
$2.91 - $3.01
52 Wk Range
1.62 - 5.06
Market Cap
$128.59M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
31
Short Interest
23.54%
Days to Cover
16.27

Recent NRX Pharmaceuticals Inc News

Why Tetra Technologies Shares Are Trading Lower By Over 15%; Here Are 20 Stocks Moving Premarket

Tetra Technologies Inc. (NYSE: TTI) shares fell 15.06% in pre-market trading after announcing a $100M stock offering. XOS, Wellchange, and J-Star are top gainers while Jianzhi, NRx, and Volato are top losers.
Avi Kapoor

NRx Pharmaceuticals (NRXP) Stock Fell 19% After Hours On Tuesday: Here's Why

NRXP stock fell after hours after NRx Pharmaceuticals announced a public stock offering to raise capital for growth and operations.
Tanya Rawat

NRx Pharmaceuticals Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

NRx Pharma (NRXP) set to release Q1 earnings on May 18. Analysts expect $19.43 million in revenue, with a loss of 11 cents per share. FDA clearance received for clinical trial.
Avi Kapoor

NRx Pharma Stock Jumps After FDA Signals Path To NDA For Ketamine Depression Drug

The FDA signals its willingness to review NRx Pharmaceuticals' NRX-100 NDA, boosting optimism around its depression treatment.
Vandana Singh
Partner Content

NRx Builds Momentum From FDA Progress To Strategic Expansion

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-19.77M
Investing Cash Flow (TTM)
-3.71M
Financing Cash Flow (TTM)
47.26M
Free Cash Flow (TTM)
-20.67M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
23.78M

Analyst Trends and Forecast

4
Apr
1
May
3
Aug
1
Sep
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$104.23M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
26.72
PB Ratio (TTM)
-
Earnings Yield % (TTM)
-17.03%
Earnings Yield % (FWD)
-16.69%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
-$0.00

Company Debt

Total Debt
$412.00K
LT Debt
-
LT Debt Issuance (TTM)
$237.00K
LT Debt Repayment (TTM)
-$204.00K
Total Cash
$26.69M
Debt to Equity
-
Issuance of Debt (TTM)
$33.00K
Repayment of Debt (TTM)
-$204.00K

Key Statistics

Open
$2.95
Close
-
Volume / Avg.
565.96K / 898.40K
Day Range
$2.91 - $3.01
52 Wk Range
1.62 - 5.06
Market Cap
$128.59M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
31
Short Interest
23.54%
Days to Cover
16.27

About

Sector
Health Care
Industry
Pharmaceuticals
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company is ...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

FAQ

Q

How do I buy NRX Pharmaceuticals (NRXP) stock?

A

You can purchase shares of NRX Pharmaceuticals (NASDAQ:NRXP) through any online brokerage.

View our list of the best stock brokerages

Q

Who are NRX Pharmaceuticals (NRXP) competitors?

Q

What is the forecast, or price target, for NRX Pharmaceuticals (NRXP) stock?

A

NRX Pharmaceuticals has a consensus price target of $29.43.

Q

What is the current price for NRX Pharmaceuticals (NRXP)?

A

The stock price for NRX Pharmaceuticals (NASDAQ: NRXP) is $2.97 last updated September 28, 2026 at 3:27 PM EDT.

Q

Does NRX Pharmaceuticals (NRXP) pay a dividend?

A

There are no upcoming dividends for NRX Pharmaceuticals.

Q

When is NRX Pharmaceuticals (NASDAQ:NRXP) reporting earnings?

A

NRX Pharmaceuticals does not have any upcoming earnings scheduled.

Q

Is NRX Pharmaceuticals (NRXP) going to split?

A

There is no upcoming split for NRX Pharmaceuticals.

Q

What sector and industry does NRX Pharmaceuticals (NRXP) operate in?

A

NRX Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved